The NCI - ECOG E4A03 trial showed longer survival and less toxicity with low-dose dexamethasone in newly patients with multiple myeloma.
Low-dose dexamethasone in patients with newly diagnosed multiple myeloma.
Low-dose dexamethasone in patients with newly…
Low-dose dexamethasone in patients with newly diagnosed multiple myeloma.
The NCI - ECOG E4A03 trial showed longer survival and less toxicity with low-dose dexamethasone in newly patients with multiple myeloma.